Pediatric hydrocarbon-related injuries in the United States: 2000-2009

Heath A Jolliff1, Erica Fletcher, Kristin J Roberts

  • 1Central Ohio Poison Center, Nationwide Children’s Hospital,Columbus, OH, USA. heath.jolliff@nationwidechildrens.org

Pediatrics
|May 8, 2013
PubMed

Insights

Hydrocarbon exposures in young children treated in US emergency departments and poison control centers declined significantly from 2000-2009. Despite this decrease, these preventable injuries remain a concern, particularly during summer months.

Area of Science:

  • Pediatric toxicology
  • Environmental health
  • Injury prevention

Background:

  • Hydrocarbon-related injuries are a significant concern in young children.
  • Understanding exposure patterns is crucial for effective prevention strategies.

Purpose of the Study:

  • To estimate national rates of hydrocarbon exposures in US children aged 5 years and younger.
  • To analyze data from emergency department visits and poison control center calls.

Main Methods:

  • Retrospective review of data from the National Poison Data System and National Electronic Injury Surveillance System (2000-2009).
  • Analysis focused on children ≤5 years with hydrocarbon-related injuries.

Main Results:

  • Over 65,000 poison center calls and an estimated 40,000 emergency department visits were recorded.
  • Ingestion was the most common injury mechanism; most cases did not require hospitalization.
  • A significant decline in exposures was observed over the decade, with seasonal peaks in summer.

Conclusions:

  • Hydrocarbon injuries in children show a declining trend, likely due to prevention efforts.
  • Despite the decline, hydrocarbons remain a major cause of preventable childhood injuries.
  • Continued vigilance and prevention efforts are necessary.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...